These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 16175591)

  • 21. The cannabis withdrawal syndrome.
    Budney AJ; Hughes JR
    Curr Opin Psychiatry; 2006 May; 19(3):233-8. PubMed ID: 16612207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Maternal cannabis use and intra-uterine growth restriction].
    Davitian C; Uzan M; Tigaizin A; Ducarme G; Dauphin H; Poncelet C
    Gynecol Obstet Fertil; 2006; 34(7-8):632-7. PubMed ID: 16890472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic cannabis use does not affect the normalization of hypothalamic-pituitary-adrenal (HPA) axis induced by methadone in heroin addicts.
    Nava F; Manzato E; Lucchini A
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1089-94. PubMed ID: 17466429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cannabinoids and psychosis.
    Sewell RA; Ranganathan M; D'Souza DC
    Int Rev Psychiatry; 2009 Apr; 21(2):152-62. PubMed ID: 19367509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cannabis hyperemesis syndrome].
    Bonnet U; Chang DI; Scherbaum N
    Fortschr Neurol Psychiatr; 2012 Feb; 80(2):98-101. PubMed ID: 21692016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clearing the smoke: what do we know about adolescent cannabis use and schizophrenia?
    Hill MN
    J Psychiatry Neurosci; 2014 Mar; 39(2):75-7. PubMed ID: 24576402
    [No Abstract]   [Full Text] [Related]  

  • 27. Environmental factors as disease accelerators during chronic hepatitis C.
    Mallat A; Hezode C; Lotersztajn S
    J Hepatol; 2008 Apr; 48(4):657-65. PubMed ID: 18279998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cognitive impairment of cannabis use].
    Lafaye G
    Rev Prat; 2013 Dec; 63(10):1428-9. PubMed ID: 24579345
    [No Abstract]   [Full Text] [Related]  

  • 29. Unheated Cannabis sativa extracts and its major compound THC-acid have potential immuno-modulating properties not mediated by CB1 and CB2 receptor coupled pathways.
    Verhoeckx KC; Korthout HA; van Meeteren-Kreikamp AP; Ehlert KA; Wang M; van der Greef J; Rodenburg RJ; Witkamp RF
    Int Immunopharmacol; 2006 Apr; 6(4):656-65. PubMed ID: 16504929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The problem of substance abuse in people with schizophrenia.
    DeLisi LE; Fleischhacker WW
    Curr Opin Psychiatry; 2015 May; 28(3):199-200. PubMed ID: 25714896
    [No Abstract]   [Full Text] [Related]  

  • 31. [How dangerous are the "new drugs"?].
    Bruhn C
    Dtsch Med Wochenschr; 2009 Feb; 134(9):p8. PubMed ID: 19242915
    [No Abstract]   [Full Text] [Related]  

  • 32. Cannabinoids inhibit human keratinocyte proliferation through a non-CB1/CB2 mechanism and have a potential therapeutic value in the treatment of psoriasis.
    Wilkinson JD; Williamson EM
    J Dermatol Sci; 2007 Feb; 45(2):87-92. PubMed ID: 17157480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis use and self-reported collisions in a representative sample of adult drivers.
    Mann RE; Adlaf E; Zhao J; Stoduto G; Ialomiteanu A; Smart RG; Asbridge M
    J Safety Res; 2007; 38(6):669-74. PubMed ID: 18054598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cannabis and pregnancy].
    Coscas S; Karila L
    Rev Prat; 2013 Dec; 63(10):1433. PubMed ID: 24579347
    [No Abstract]   [Full Text] [Related]  

  • 35. A role for cannabinoid receptors, but not endogenous opioids, in the antinociceptive activity of the CB2-selective agonist, GW405833.
    Whiteside GT; Gottshall SL; Boulet JM; Chaffer SM; Harrison JE; Pearson MS; Turchin PI; Mark L; Garrison AE; Valenzano KJ
    Eur J Pharmacol; 2005 Dec; 528(1-3):65-72. PubMed ID: 16316650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cannabis affects driving skills].
    Khiabani HZ; Christophersen AS; Mørland J
    Tidsskr Nor Laegeforen; 2007 Mar; 127(5):583-4. PubMed ID: 17332811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma.
    Xu X; Liu Y; Huang S; Liu G; Xie C; Zhou J; Fan W; Li Q; Wang Q; Zhong D; Miao X
    Cancer Genet Cytogenet; 2006 Nov; 171(1):31-8. PubMed ID: 17074588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample.
    Zvolensky MJ; Bernstein A; Sachs-Ericsson N; Schmidt NB; Buckner JD; Bonn-Miller MO
    J Psychiatr Res; 2006 Sep; 40(6):477-86. PubMed ID: 16271364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cannabis abuse in patients with schizophrenia: pattern and effects on symptomatology.
    Rehman IU; Farooq S
    J Coll Physicians Surg Pak; 2007 Mar; 17(3):158-61. PubMed ID: 17374302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.